Accumulating evidences support the importance of RNA biology in the hallmarks of cancer. Post-transcriptional steps of gene expression (pre-mRNA splicing, polyadenylation, stability, translation, localization and modifications) as well as the functions of non-coding RNAs are increasingly diverse. It is therefore challenging to comprehend this complexity in the context of cancer.
The internationally renowned experts invited to this symposium will present the recent advances in our understanding of RNA biology in cancer. This will be complemented by at least 10 selected talks, as well as poster presentations.
The symposium is intended to bring together RNA and cancer biologists. It is expected that the small size of the attendance (max. 150) will foster stimulating discussions that will lead to innovative collaborations.
– Regulators of RNA metabolism as oncoproteins and tumor suppressors
– Oncogenic signalling to RNAs and anti-cancer targeted therapies
– RNA modifications in cancer development and progression
– Extracellular RNA trafficking
– RNA-based reprograming of cancer cell metabolism
– Immune response and RNA biology
Martin Dutertre (Curie institute, FR), David Stanek (IMG, CZ), Petr Svoboda (IMG, CZ), Stéphan Vagner (Curie institute, FR), Juan Valcarcel (CRG, ES), Sandra Wolin (NCI, USA)
Registration fee: 150 Euros – Registration and full payment due no later than March 20, 2017.
The registration fees include access to sessions, coffee breaks, two dinners (Sunday and Monday) and two lunches (Monday and Tuesday). Payment must be made in full at the time of registration only by Credit Card.
Abstracts are welcome on all scientific topics related to the symposium and must be submitted electronically by March 20, 2017. Those who wish to submit an abstract must first register to attend the conference. Selection of abstracts for oral (at least 10) and poster presentations will be made by the organizers. Acceptance of abstracts and their status (talk/poster) will be sent by email no later than April 20, 2017. The audience will be limited to 150 participants.